Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 03835L702
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 83,854 · Class: 8.2%
- Heights Capital Management, Inc.
Shares: 83,854 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-26-000020
- Form type
- SCHEDULE 13G/A
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership